Advertisement

Topics

Companies Related to "Leuprorelin Associated With Radiotherapy Versus Leuprorelin Alone in T3 - T4 or pT3 (on Biopsy) N0, M0 Prostate Cancer" [Most Relevant Company Matches] RSS

20:28 EDT 23rd October 2018 | BioPortfolio

Here are the most relevant search results for "Leuprorelin Associated With Radiotherapy Versus Leuprorelin Alone in T3 - T4 or pT3 (on Biopsy) N0, M0 Prostate Cancer" found in our extensive corporate database of over 50,000 company records.

Showing "Leuprorelin Associated With Radiotherapy Versus Leuprorelin Alone Biopsy" Companies 1–25 of 106

Relevant

Precision Biopsy, LLC

Precision Biopsy, LLC is a privately-held startup company formed by Allied Minds, Inc. in cooperation with the University of Colorado to commercialize a revolutionary optical biopsy technology designed to improve the accuracy and reliability of prostate biopsies and the diagnosis of prostate cancer. www.precisionbiopsy.com


Psimei Pharmaceuticals plc

Psimei Pharmaceuticals plc, founded in 2001, is a world leader in the development of Boron Cellular Radiotherapy (BCR) products. These are designed to significantly improve the clinical effectiveness of radiotherapy in the treatment of cancer. At present only 30% of cancer patients receiving radiotherapy are "cured". This equates to complete clinical responses for up to 5 years. Psimei is currentl...

ProCertus BioPharm, Inc.

ProCertus BioPharm is an oncology-based pharmaceutical company whose primary mission is to protect cancer patients against the side effects of chemotherapy and radiotherapy.ProCertus has established proof of concept in animal models for its product candidates, DermX, ProDermaCel™, and OralX, proprietary pharmaceuticals designed to reduce or eliminate the side effects associated with cancer thera...


PAR Scientific A/S

PAR Scientific A/S was founded 1986 in Denmark. We are a subsidiary of S&S X-Ray Products Inc., USA. All development activities, both mechanical, electronics and software are taking place in Denmark. We manufacture high technology equipment for optimization of radiotherapy treatment and have more than 650 units installed in 375 radiotherapy centres throughout the world. Our Ideology is to develop,...

Augmenix, Inc.

Augmenix, Inc. is a privately held company based in Waltham, Mass., focused on the development and commercialization of implantable biomaterial based solutions for improved radiotherapy safety and/or efficacy. Augmenix's first product, SpaceOAR system is an injectable tissue spacer that will decrease rectal morbidity or enable improved efficacy in prostate radiotherapy. The company was founded in ...

Devicor® Medical Products, Inc.

Devicor Medical Products, headquartered in Cincinnati, Ohio, has more than 400 employees around the world. As the global market leader, Devicor is committed to advancing technology to help clinicians accurately diagnose breast disease, such as breast cancer, through minimally invasive procedures. Devicor’s product portfolio includes the world-renowned...

NeoMatrix, LLC

Based in Irvine, Calif., NeoMatrix© develops innovative devices that allow women and their doctors to promote optimal breast health. The company's premier product, the HALO Breast Pap Test System, is the first fully automated, noninvasive breast cancer risk assessment tool designed for use in the primary care office setting. The System has been FDA cleared for the collection of nipple aspirate fl...

NephroPath

Time to diagnosis can have a critical effect on the ultimate outcome of many renal diseases, and when a patient undergoes an invasive procedure such as a renal biopsy, there can be significant anxiety while the results are pending. Over the last 14 years, Dr. Patrick Walker, our Director and one of the nation's leading renal pathologists, has developed a unique system for rapid processing of renal...

Scantek Medical, Inc

Biopsy and screening clinical trials were conducted at well-established U.S. institutions to assess and validate BreastCare's usefulness in detecting breast cancer. BreastCare was found to be very accurate in terms of the device's documented sensitivity (true positives for cancer) and specificity (true negatives - no cancer detectable by accepted medical methods) indices in relation to the biopsy ...

Biothera

Biothera, a privately held U.S. biotechnology company, is developing Imprime PGG, a late clinical stage biologic that modulates the immune response to cancer. Data from the most recent randomized phase 2 study of Imprime PGG in first line non-squamous non-small cell lung cancer (NSCLC) was featured as a late-breaking abstract in the Immunotherapy of Cancer...

Personal Genome Diagnostics Inc.

Personal Genome Diagnostics (PGDx) empowers the fight against cancer by unlocking actionable information from the genome. We are committed to developing a portfolio of regulated tissue-based and liquid biopsy genomic products for laboratories worldwide. PGDx was established by researchers from Johns Hopkins University who are pioneers in cancer genome sequ...

Personal Genome Diagnostics, Inc.

Personal Genome Diagnostics (PGDx) empowers the fight against cancer by unlocking actionable information from the genome. We are committed to developing a portfolio of regulated tissue-based and liquid biopsy genomic products for laboratories worldwide. PGDx was established by researchers from Johns Hopkins University who are pioneers in cancer genome sequ...

Concord Medical Services Holdings Limited

Concord Medical operates the largest network of radiotherapy and diagnostic imaging facilities in China in terms of revenues and the total number of facilities in operation per available statistics. The Company currently operates a network of more than 89 centers spanning 37 cities and 21 provinces and administrative regions in China. Under long-term arrangements with top-tier hospitals in Chi...

RC Cancer Centers

Each year thousands of patients from around the world and across the United States turn to RC Cancer Centers seeking a cure for their prostate cancer and learn why they are The Choice for Saving Lives. Founded in 1979, Radiotherapy Centers of Georgia, a division of RC Cancer Centers, has earned a reputation for being one of the country's top cancer treatment and research facilities because of its ...

Precision Biopsy, Inc.

Cellanyx Diagnostics

Cellanyx Diagnostics is developing a proprietary living cell phenotypic cancer diagnostic platform to aid clinical decision making. The company’s unique ‘biopsy-on-a-chip’ methodology provides quantitative, actionable assessment of individual cancer cells in biopsy samples using multiple phenotypic biochemical and biophysical markers of tumor ...

Spectrascience

SpectraSCIENCE, Inc. has developed a proprietary WavSTAT™ Optical Biopsy System capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body and without waiting days for a pathology report. The WavSTAT™ Optical Biopsy System uses a spectrophotometry technique known as Laser Induced Fluorescence (LIF). During LIF spectrophotometry,...

United Medical Systems

UMS provides affordable, advanced mobile medical services. Their unique transportable platform offers the appearance of a full-time, in-house program, without incurring the cost and burden associated with a fixed program. United Medical Systems pioneered the concept of shared mobile medical services for Urology, including Lithotripsy, BPH and ureteral ston...

Nucletron Corporation

Nucletron is a radiotherapy company that specializes in the development, manufacture, sales, service and support of the world’s most innovative products for cancer treatment.

Nucletron Corporation (HQ)

Nucletron is a radiotherapy company that specializes in the development, manufacture, sales, service and support of the world’s most innovative products for cancer treatment.

Nucletron Corporation (UK)

Nucletron is a radiotherapy company that specializes in the development, manufacture, sales, service and support of the world’s most innovative products for cancer treatment.

Probably Relevant

Nanobiotix

Nanobiotix is an oncology focused nanomedicine company developing an innovative nanoparticle technology. Nanobiotix is developing new tools for cancer which utilize a physical mode of action at the cellular level of the cancer cell. This disruptive approach may reshape future treatment opportunities. Cancer is one of the leading causes of death worldwide and accounted for 7.6 million deaths (a...

Lumitron Technologies, Inc.

Based in Irvine, California, Lumitron Technology Inc. was established to develop and commercialize unique X‐ray systems that enable revolutionary new capabilities for high‐fidelity imaging, ultra‐low dose imaging and hyper‐precision radiotherapy.

IBA Dosimetry

IBA Dosimetry offers a full range of innovative solutions for radiotherapy, radiodiagnostics, calibration service and imaging markers. Its measuring instruments and software enable medical physicists and radiologists to perform the necessary quality assurance and calibration procedures.

DySIS Colposcopy

The DySIS colposcope differs from traditional colposcopes by measuring the cervical epithelium automatically, producing a map of the cervix which assists the clinician with assessing the cervix, identifying biopsy locations and performing treatment if needed.


More From BioPortfolio on "Leuprorelin Associated With Radiotherapy Versus Leuprorelin Alone in T3 - T4 or pT3 (on Biopsy) N0, M0 Prostate Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks